The
blood-brain barrier blocks the development of biologic pharmaceuticals
for brain
ArmaGen®
provides platform technology solutions to the 'blood-brain barrier'
problem, and can non-invasively target recombinant proteins, therapeutic
monoclonal antibodies, and siRNA to the brain
|
Brain
blood vessels form the blood-brain barrier and block drug access
to the brain
|
| News
December 8, 2011 |
ArmaGen®
granted U.S. patents on IgG-neurotrophin fusion proteins
for targeted brain delivery
Brain-penetrating
neurotrophins. Three
new patents on IgG-neurotrophin fusion proteins for
targeted brain drug delivery across the human blood-brain
barrier (BBB) have been issued or allowed....
|
|
|
